Mrv1909 04012121582D 18 18 0 0 1 0 999 V2000 -0.7145 2.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 2.4750 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.7145 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.0000 -1.6500 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -2.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.4125 -2.3645 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4125 -0.9355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 3.7125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 3.7125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 6 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 5 6 1 0 0 0 0 6 7 2 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 9 12 2 0 0 0 0 7 13 1 0 0 0 0 13 14 1 0 0 0 0 13 15 2 0 0 0 0 4 15 1 0 0 0 0 2 16 1 0 0 0 0 16 17 1 0 0 0 0 16 18 2 0 0 0 0 M END > DB16683 > drugbank > N[C@@H](CC1=CC=C(OP(O)(O)=O)C(O)=C1)C(O)=O > InChI=1S/C9H12NO7P/c10-6(9(12)13)3-5-1-2-8(7(11)4-5)17-18(14,15)16/h1-2,4,6,11H,3,10H2,(H,12,13)(H2,14,15,16)/t6-/m0/s1 > YNDMEEULGSTYJT-LURJTMIESA-N > C9H12NO7P > 277.169 > 277.035138728 > 7 > 30 > 0.9569296874066728 > 23.740620743306895 > 1 > 5 > 0 > 0 > (2S)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl]propanoic acid > -0.74 > -1.3408511900646876 > -2.22 > 0 > -2 > 1 > -2 > 2.178285276339968 > 1.2581548591812939 > 9.41357887250502 > 150.31 > 59.95100000000001 > 5 > 1 > 1.66e+00 g/l > (2S)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl]propanoic acid > 0 > DB16683 > approved; investigational > Foslevodopa > 3-hydroxy-O-phosphono-L-tyrosine; Foslevodopa; Levodopa-4'-monophosphate > Vyalev > Produodopa $$$$